I absolutely agree.
Why weren't they compared to other children who were in similar situations. I'm guessing the population is quite small and variable as it's quite rare but no mention of the standard disease progression.
Would they have died? Where that assumption from? People are making assumptions left right and centre and making investment decisions based on them.
I'm merely pointing out these assumptions aren't valid.
The clinical results may be impressive. Maybe they're not. Again, who knows man.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-96
-
-
- There are more pages in this discussion • 328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
0.030(3.13%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $4.704M | 4.708M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 274051 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 0.985 |
3 | 116426 | 0.980 |
2 | 84419 | 0.975 |
3 | 54211 | 0.970 |
5 | 98141 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 274051 | 2 |
1.005 | 49212 | 4 |
1.010 | 31212 | 2 |
1.015 | 72652 | 4 |
1.020 | 560 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |